What does CUSIP 359616109 represent in this 13F holders report?

CUSIP 359616109 is the security identifier for FULC - Fulcrum Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held FULC - Fulcrum Therapeutics, Inc. - Common Stock in Q1 2021?

68 institutional investors reported FULC - Fulcrum Therapeutics, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Fulcrum Therapeutics, Inc. - Common Stock (FULC)

CUSIP: 359616109

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 67,171,444
Total 13F shares: 26,913,060
Share change: +3,860,351
Total reported value: $317,031,000
Price per share: $11.78
Number of holders: 68
Value change: +$45,552,581
Number of buys: 33
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP 359616109?
CUSIP 359616109 identifies FULC - Fulcrum Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 359616109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FULC - Fulcrum Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TRV GP III, LLC	13F	Company	8.9%	5,962,202	$69,817,000	—	31 Dec 2020	13F
TRV GP IV, LLC	13F	Company	3.5%	2,343,154	$27,438,000	—	31 Dec 2020	13F
RTW INVESTMENTS, LP	13F	Company	3.1%	2,071,409	$24,256,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	2.6%	1,749,736	$20,489,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	2%	1,338,123	$15,669,000	—	31 Dec 2020	13F
Casdin Capital, LLC	13F	Company	1.8%	1,241,176	$14,534,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	1.6%	1,043,284	$12,217,000	—	31 Dec 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1%	682,500	$7,992,000	—	31 Dec 2020	13F
Alphabet Inc.	13F	Company	1%	678,141	$7,941,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	0.98%	661,206	$7,743,000	—	31 Dec 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.67%	452,797	$5,302,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	0.65%	437,700	$5,125,000	—	31 Dec 2020	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.61%	410,714	$4,809,000	—	31 Dec 2020	13F
Samsara BioCapital, LLC	13F	Company	0.44%	294,118	$3,444,000	—	31 Dec 2020	13F
BESSEMER GROUP INC	13F	Company	0.43%	285,714	$3,346,000	—	31 Dec 2020	13F
Burrage Capital Management LLC	13F	Company	0.4%	271,926	$3,184,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.36%	239,449	$2,804,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.34%	229,634	$2,688,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.31%	207,670	$2,431,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.28%	190,009	$2,225,000	—	31 Dec 2020	13F
Sio Capital Management, LLC	13F	Company	0.22%	146,272	$1,713,000	—	31 Dec 2020	13F
FIDUCIARY TRUST CO	13F	Company	0.19%	124,999	$1,464,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	117,754	$1,379,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.15%	98,898	$1,158,000	—	31 Dec 2020	13F
Opaleye Management Inc.	13F	Company	0.13%	88,300	$1,034,000	—	31 Dec 2020	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.12%	83,550	$978,000	—	31 Dec 2020	13F
Darwin Global Management, Ltd.	13F	Company	0.09%	61,313	$718,000	—	31 Dec 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.08%	55,734	$653,000	—	31 Dec 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.07%	49,908	$584,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.06%	43,012	$504,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.06%	39,800	$466,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.06%	38,862	$455,000	—	31 Dec 2020	13F
COUNTRY TRUST BANK	13F	Company	0.06%	37,341	$437,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	37,014	$434,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	30,000	$351,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.04%	27,647	$324,000	—	31 Dec 2020	13F
PDT Partners, LLC	13F	Company	0.04%	23,710	$278,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	22,701	$266,000	—	31 Dec 2020	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.03%	20,757	$243,000	—	31 Dec 2020	13F
BRANDYWINE MANAGERS, LLC	13F	Company	0.03%	20,388	$239,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.03%	19,900	$233,000	—	31 Dec 2020	13F
Engineers Gate Manager LP	13F	Company	0.03%	19,811	$232,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	18,807	$221,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	16,972	$199,000	—	31 Dec 2020	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	16,209	$190,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	15,700	$184,000	—	31 Dec 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.02%	15,692	$184,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	14,857	$174,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	12,267	$144,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	11,865	$139,000	—	31 Dec 2020	13F

Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock (FULC) as of Q1 2021

As of 31 Mar 2021, Fulcrum Therapeutics, Inc. - Common Stock (FULC) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,913,060 shares. The largest 10 holders included TRV GP III, LLC, RTW INVESTMENTS, LP, FMR LLC, TRV GP IV, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Casdin Capital, LLC, BlackRock Inc., COWEN AND COMPANY, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and VANGUARD GROUP INC. This page lists 68 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.